Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Defining the relationship between obstetricians and maternal-fetal medicine specialists

Article Abstract:

Most obstetricians will refer a pregnant women with a high-risk pregnancy to a maternal-fetal medicine specialist, according to a survey of 106 obstetricians. High-risk conditions included fatty liver, portal hypertension, pulmonary hypertension, transplantations, fetal hydrops, cytogenetic abnormalities, fetal heart diseases, isoimmunization, and twin-twin transfusion syndrome.

Author: Vintzileos, Anthony M., Ananth, Cande V., Smulian, John C., Knuppel, Robert A., Scorza, William E.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
Surveys, Medical referral, Obstetricians

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Intrapartum fever at term: serum and histologic markers of inflammation

Article Abstract:

A fever during labor may not necessarily be a sign of an intrauterine infection, according to a study of 94 pregnant women. Only 31% of the women with fever had evidence of an intrauterine infection. However, all of these women had higher blood levels of interleukin-6 than women who did not have fever.

Author: Vintzileos, Anthony M., Ananth, Cande V., Smulian, John C., Bhandari, Vineet, Shen-Schwarz, Susan, Quashie, Carlene, Lai-Lin, Yu-Ling
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2003
Physiological aspects, Labor (Obstetrics), Fever, Hyperthermia, Interleukin-6, Chorioamnionitis, Labour (Obstetrics)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


An economic evaluation of prenatal strategies for detection of trisomy 18

Article Abstract:

Routine amniocentesis to detect trisomy 18 in pregnant women with abnormal screening tests or choroid plexus cysts cannot be justified in a cost-benefit analysis. Trisomy 18 is a chromosomal defect which causes the death of 95% of affected children before birth or during the first year of life. Researchers compared no diagnostic testing, amniocentesis for every high-risk patient, or genetic ultrasonography plus amniocentesis, when indicated. Universal amniocentesis would cost about $12 million annually, and result in 40 fetal losses from the test procedure. Genetic ultrasonography with targeted amniocentesis would cost $5 million annually and cause 8 fetal losses.

Author: Vintzileos, Anthony M., Ananth, Cande V., Smulian, John C., Beazoglou, Tryfon, Knuppel, Robert A., Fisher, Allan J., Day-Salvatore, Debra
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
Economic aspects, Diagnosis, Trisomy, Amniocentesis, Prenatal diagnosis, Prenatal ultrasonography, Ultrasonics in obstetrics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: A study to investigate the relationship between dietary fibre intake and gastrointestinal diseases. Food consumption patterns in Italy: the INN-CA study, 1994-1996
  • Abstracts: Relationship between market competition and the activities and attitudes of medical school faculty. Resident physicians' preparedness to provide cross-cultural care
  • Abstracts: Ethical issues concerning research in complementary and alternative medicine. The ethics of placebo-controlled trials -- a middle ground
  • Abstracts: Does the combined antenatal use of corticosteroids and antibiotics increase late-onset neonatal sepsis in the very low birth weight infant?
  • Abstracts: A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.